You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

antibody-drug conjugate (ADC)

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in New York (STI-6129)

Not yet recruiting
  • Advanced Solid Tumor
  • STI-6129
  • New York, New York
    Columbia University Medical Center
Jan 26, 2023

HER2 Positive Metastatic Breast Cancer Trial in Worldwide (ARX788)

Active, not recruiting
  • HER2 Positive Metastatic Breast Cancer
  • Glendale, California
  • +52 more
Oct 25, 2022

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
Has Results
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Gastric Cancer, HER2 Overexpressing Gastric Carcinoma Trial in Beijing (RC48-ADC)

Completed
  • Gastric Cancer
  • HER2 Overexpressing Gastric Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jan 12, 2022

Breast Cancer Trial in Shanghai (SHR-A1811, TROP2 ADC)

Active, not recruiting
  • Breast Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 11, 2023

Breast Cancer Trial in Spain (U3 1402)

Recruiting
  • Breast Cancer
  • U3 1402
  • Badalona, Barcelona, Spain
  • +9 more
Apr 1, 2022

Solid Tumor Trial in Belgium, Netherlands, United Kingdom (SYD985 + Niraparib)

Active, not recruiting
  • Solid Tumor
  • SYD985 + Niraparib
  • Antwerp, Belgium
  • +5 more
Jan 23, 2023

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma Trial in

Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +13 more
  • Polatuzumab Vedotin
  • +3 more
  • Scottsdale, Arizona
  • +11 more
Aug 23, 2022

Melanoma, Stage II, HER2-positive, Advanced Melanoma Trial (RC48-ADC)

Not yet recruiting
  • Melanoma, Stage II
  • +2 more
  • (no location specified)
Nov 29, 2021

Cancer Trial (Antibody-Drug Conjugate)

Not yet recruiting
  • Cancer
  • Antibody-Drug Conjugate
  • (no location specified)
Aug 23, 2023

DLBCL, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Tampa, Florida
  • +1 more
Jan 12, 2022

Gynecological Malignancy Trial in Beijing (RC48-ADC)

Recruiting
  • Gynecological Malignancy
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences Cancer Hospital
Jan 6, 2022

Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma, Ann Arbor Stage II Primary Mediastinal (Thymic) Large

Recruiting
  • Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma
  • +3 more
  • Brentuximab Vedotin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 10, 2022

Advanced Solid Tumors Trial (FDA022 Monoclonal antibody-drug conjugate for injection)

Not yet recruiting
  • Advanced Solid Tumors
  • FDA022 Monoclonal antibody-drug conjugate for injection
  • (no location specified)
Sep 29, 2022

B-cell Lymphoma, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial (BN301)

Not yet recruiting
  • B-cell Lymphoma
  • +4 more
  • (no location specified)
Nov 9, 2022

Ovary Cancer, Cervix Cancer, Endometrium Cancer Trial in Worldwide (Tisotumab Vedotin (HuMax-TF-ADC))

Completed
Has Results
  • Ovary Cancer
  • +7 more
  • Tisotumab Vedotin (HuMax-TF-ADC)
  • Orange, California
  • +28 more
Nov 29, 2021

Breast Cancer Trial in Boston (Talazoparib, Sacituzumab Govitecan)

Recruiting
  • Breast Cancer
  • Boston, Massachusetts
  • +1 more
Jan 6, 2023

Urothelial Carcinoma Trial in Beijing (RC48-ADC)

Active, not recruiting
  • Urothelial Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Sep 14, 2021

Advanced NSCLC Trial in United States (REGN5093-M114)

Recruiting
  • Advanced NSCLC
  • Aurora, Colorado
  • +7 more
Aug 11, 2022

Advanced Solid Tumor Trial (HS-20093)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Oct 29, 2023

Breast Cancer, Urothelial Carcinoma Trial in Worldwide (Trastuzumab deruxtecan, Nivolumab)

Active, not recruiting
  • Breast Cancer
  • Urothelial Carcinoma
  • Santa Monica, California
  • +28 more
Aug 11, 2021

The Rechallenge of ADCs in MBC Patients

Active, not recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 5, 2022

Urothelial Carcinoma Trial in China (RC48-ADC)

Active, not recruiting
  • Urothelial Carcinoma
  • Hefei, Anhui, China
  • +7 more
Feb 20, 2022

Cancer, Cancer, Lung Trial in Fairfax (CPO301)

Recruiting
  • Cancer
  • Cancer, Lung
  • Fairfax, Virginia
    NEXT Virginia
Jul 10, 2023

DLBCL Unclassifiable, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Trial in Duarte,

Recruiting
  • Diffuse Large B-Cell Lymphoma Unclassifiable
  • +6 more
  • Duarte, California
  • +1 more
Oct 1, 2021